RE:RE:CAR-T updateSeptember 27, 2023 - Pfizer purchases US$25 Million of Caribou common shares.
Rachel Haurwitz, PhD, Caribou’s president and chief executive officer said “We are actively advancing our allogeneic CAR-T cell therapy pipeline and look forward to providing updates from all of our [P1/2] programs over the next six months.
https://investor.cariboubio.com/news-releases/news-release-details/caribou-biosciences-announces-25-million-equity-investment